Inhibition of PIK3CA with BYL719 can overcome resistance to cetuximab in squamous cell carcinoma of the head and neck (SCCHN)
- Authors
- Munster, P[Munster, Pamela]; Elkabets, M[Elkabets, Moshe]; Gilbert, J[Gilbert, Jill]; Razak, ARA[Razak, Albiruni R. Abdul]; Ahn, MJ[Ahn, Myung-Ju]; Yen, CJ[Yen, Chia-Jui]; Lee, SH[Lee, Se-Hoon]; Wang, HM[Wang, Hung-Ming]; van Herpen, C[van Herpen, Carla]; Lim, WT[Lim, Wan-Teck]; Demanse, D[Demanse, David]; Pal, RR[Pal, Rupam Ranjan]; Huang, A[Huang, Alan]; Sheng, Q[Sheng, Qing]; Lambertini, C[Lambertini, Chiara]; Peters, M[Peters, Malte]; Coughlin, C[Coughlin, Christina]; Scaltriti, M[Scaltriti, Maurizio]; Baselga, J[Baselga, Jose]; Blumenschein, G[Blumenschein, George]
- Issue Date
- Jul-2015
- Publisher
- AMER ASSOC CANCER RESEARCH
- Citation
- MOLECULAR CANCER THERAPEUTICS, v.14, no.7
- Indexed
- SCIE
SCOPUS
- Journal Title
- MOLECULAR CANCER THERAPEUTICS
- Volume
- 14
- Number
- 7
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/43554
- DOI
- 10.1158/1538-8514.PI3K14-A46
- ISSN
- 1535-7163
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.